-+ 0.00%
-+ 0.00%
-+ 0.00%

Litchfield Hills Initiates Coverage On Silexion Therapeutics with Buy Rating, Announces Price Target of $6

Benzinga·12/15/2025 14:45:56
Listen to the news
Litchfield Hills analyst Theodore O'Neill initiates coverage on Silexion Therapeutics (NASDAQ:SLXN) with a Buy rating and announces Price Target of $6.